30
Total investments
19
Early stage
3
Mid stage
3
Late stage
14y
Years active
Portfolio
28 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2021
Founded in 2018, Wheel stands at the forefront of health technology, driving the evolution of healthcare for tomorrow. Wheels platform offers AI-assisted patient experiences, tailored care programs, and top-tier clinicians, enabling seamless nationwide care at an unprecedented scale. Having facilitated millions of patient visits, Wheel collaborates with a diverse client base of life sciences, payers, digital health, and retail customers including Amazon Clinic and GoodRx. Discover more at wheel.com.
Investor
2020
The open ocean is Earth’s largest and most power-dense renewable energy resource. We’re harnessing that resource to produce the cheapest energy on the planet for clean compute at sea and renewable fuels to shore.
Investor
2020
Soda Health is a healthcare technology company founded on the promise of reducing health inequity. We provide Smart Benefits that connect people to products and services they need, when they need them, so they can live healthier lives. We close health equity gaps and lower the cost of healthcare by bridging the gap between the cost of living and living healthier. We partner with health plans and retailers to deliver expansive benefits for things like healthy foods, OTC medications, or transportation. Beyond facilitating transactions, Soda Health understands each individual’s needs and connects people to the resources they need to live healthier lives.
Investor
2020
As a pioneer in telemedicine for Skilled Nursing Facilities, we are committed to revolutionizing senior care by breaking down barriers and delivering exceptional healthcare without limitations. Established in 2020, our groundbreaking platform has achieved a remarkable 50%+ reduction in patient transfers from Skilled Nursing Facilities (SNFs) to Emergency Departments.
At Curve Health, we seamlessly integrate telemedicine, electronic health data, predictive analytics, and billing into one unified platform. This comprehensive approach ensures higher quality care, substantial return on investment, and an unparalleled patient experience.
To discover more about our innovative solutions, visit us at: https://www.curvehealth.com/
Investor
2020
At Satellite Bio, we’re on a journey – a quest to treat some of the most elusive diseases known to humankind by pioneering Tissue Therapeutics, an entirely new category of regenerative medicine.
With the first-of-its-kind SAT (Satellite Adaptive Tissues) platform, Satellite Bio can turn virtually any cell type into bioengineered tissues that are integrated into the body to restore natural function. These tissues, called Satellites, can deliver the comprehensive cellular response needed to repair or even replace critical organ functions in patients with diseases caused by the interaction of genetic and environmental factors. The SAT platform is an unprecedented technology with the potential to drive a pipeline of sophisticated cell-based therapeutic solutions that tackle a broad range of elusive diseases.
Satellite Bio’s quest is as audacious as it is clear: bring new hope to patients and families suffering from elusive diseases. Tissue Therapeutics is how it will deliver on that promise—and why it is deeply committed to leading and realizing the potential of this exciting new frontier in regenerative medicine.
Investor
2019
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules. Combining advanced cell engineering, high-throughput chemistry, and automation we are engineering best-in-class drugs across rare disease, oncology, and immunology.
Investor
2019
At Modern Animal, we are on a mission to better the lives of animals by building a place that’s better for all of us who love them. During our collective decades in the veterinary industry, we observed numerous pain points for both pet owners and veterinarians, ultimately concluding that through intentional design and innovations in technology, we could deliver a better experience.
Today, we have 10+ clinics across Greater Los Angeles and the San Francisco Bay Area, which so far, have garnered rave reviews.
We have also raised capital from leading venture capital funds (including Founders Fund, True Ventures, and Upfront Ventures), which will allow us to continue to bring modern veterinary care to more practitioners and pet owners.
We are a new kind of veterinary company; we believe a better one. We are just getting started, and we cannot wait to meet you.
Investor
2019
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections.
Investor
2019
Notion blends your everyday work tools into one. Product roadmap? Company wiki? Meeting notes? With Notion, theyre all in one place, and totally customizable to meet the needs of any workflow. Its the all-in-one workspace for you, your team, and your whole company.
We humans are toolmakers by nature, but most of us cant build or modify the software we use every day — arguably our most powerful tool. Our team at Notion is on a mission to make it possible for everyone to shape the tools that shape their lives.
Investor
2018
ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.
Investor
2018
Rebellion Defense builds the modern mission stack to detect and deter adversaries at scale.
Today, national security is defined by technological superiority. Rebellion delivers the software advantage to deter threats and drive mission success. Our freedoms depend on outthinking our adversaries, and software will shape who leads.
We bring together groundbreaking talent who have built the world’s most successful consumer technologies and national security leaders who deeply understand the mission. Together, we are creating the products that equip our service members to see ahead, understand, and act first.
Our people are passionate about creating a company where technologists empower the military and our civil servants to solve some of the hardest problems in government.
We are hiring incredible technologists to work on products that defend democracy, humanitarian values, and the rule of law.
Investor
2018
At Devoted Health, we’re on a mission to dramatically improve the health and well-being of older Americans by caring for every person like family. Founded in 2017, weve grown fast and now serve members all across the United States. Weve gathered smart, diverse, and big-hearted people to create a new kind of all-in-one healthcare company — one that combines compassion, health insurance, clinical care, service, and technology -- to deliver a complete and integrated healthcare solution that delivers high quality care that everyone would want for someone they love. Were only just getting started! So join us on this mission: https://devoted.com/careers/
Investor
2017
Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest-growing industries. We are a publicly traded life science technology company that is leveraging novel, next-generation sequencing (NGS) and multi-omics technologies to build products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue.
We are committed to unlocking the potential of our core technologies to reshape the future of genomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact in a rapidly expanding company. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.
Show all 28 investments ↓
Experience · 33 entries
All (33)
Investments (30)
Founder (1)
2021
Investor
2021
Founded in 2018, Wheel stands at the forefront of health technology, driving the evolution of healthcare for tomorrow. Wheels platform offers AI-assisted patient experiences, tailored care programs, and top-tier clinicians, enabling seamless nationwide care at an unprecedented scale. Having facilitated millions of patient visits, Wheel collaborates with a diverse client base of life sciences, payers, digital health, and retail customers including Amazon Clinic and GoodRx. Discover more at wheel.com.
2020
Investor
2020
The open ocean is Earth’s largest and most power-dense renewable energy resource. We’re harnessing that resource to produce the cheapest energy on the planet for clean compute at sea and renewable fuels to shore.
Investor
2020
Soda Health is a healthcare technology company founded on the promise of reducing health inequity. We provide Smart Benefits that connect people to products and services they need, when they need them, so they can live healthier lives. We close health equity gaps and lower the cost of healthcare by bridging the gap between the cost of living and living healthier. We partner with health plans and retailers to deliver expansive benefits for things like healthy foods, OTC medications, or transportation. Beyond facilitating transactions, Soda Health understands each individual’s needs and connects people to the resources they need to live healthier lives.
Investor
2020
As a pioneer in telemedicine for Skilled Nursing Facilities, we are committed to revolutionizing senior care by breaking down barriers and delivering exceptional healthcare without limitations. Established in 2020, our groundbreaking platform has achieved a remarkable 50%+ reduction in patient transfers from Skilled Nursing Facilities (SNFs) to Emergency Departments.
At Curve Health, we seamlessly integrate telemedicine, electronic health data, predictive analytics, and billing into one unified platform. This comprehensive approach ensures higher quality care, substantial return on investment, and an unparalleled patient experience.
To discover more about our innovative solutions, visit us at: https://www.curvehealth.com/
Investor
2020
At Satellite Bio, we’re on a journey – a quest to treat some of the most elusive diseases known to humankind by pioneering Tissue Therapeutics, an entirely new category of regenerative medicine.
With the first-of-its-kind SAT (Satellite Adaptive Tissues) platform, Satellite Bio can turn virtually any cell type into bioengineered tissues that are integrated into the body to restore natural function. These tissues, called Satellites, can deliver the comprehensive cellular response needed to repair or even replace critical organ functions in patients with diseases caused by the interaction of genetic and environmental factors. The SAT platform is an unprecedented technology with the potential to drive a pipeline of sophisticated cell-based therapeutic solutions that tackle a broad range of elusive diseases.
Satellite Bio’s quest is as audacious as it is clear: bring new hope to patients and families suffering from elusive diseases. Tissue Therapeutics is how it will deliver on that promise—and why it is deeply committed to leading and realizing the potential of this exciting new frontier in regenerative medicine.
Show all 33 entries ↓
Investment activity
2012–2021 · 30 investments
Recent (last 2 years)Earlier
